Darryl Carrington

1.6k total citations · 1 hit paper
7 papers, 1.4k citations indexed

About

Darryl Carrington is a scholar working on Physiology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Darryl Carrington has authored 7 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 4 papers in Pharmacology and 2 papers in Computational Theory and Mathematics. Recurrent topics in Darryl Carrington's work include Alzheimer's disease research and treatments (6 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Computational Drug Discovery Methods (2 papers). Darryl Carrington is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Computational Drug Discovery Methods (2 papers). Darryl Carrington collaborates with scholars based in Australia, United States and Sweden. Darryl Carrington's co-authors include Ashley I. Bush, Robert A. Cherny, Colin L. Masters, Konrad Beyreuther, Christine Mavros, Irene Volitakis, Kevin J. Barnham, Cyril C. Curtain, Roberto Cappai and Deborah J. Tew and has published in prestigious journals such as Journal of Biological Chemistry, The FASEB Journal and Alzheimer s & Dementia.

In The Last Decade

Darryl Carrington

6 papers receiving 1.4k citations

Hit Papers

Metal-Protein Attenuation With Iodochlorhydroxyquin (Clio... 2003 2026 2010 2018 2003 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease
    2003 810 citations Craig Ritchie, Ashley I. Bush et al. Archives of Neurology profile →

Peers

Darryl Carrington
Christine Mavros Australia
Fedá E. Ali Australia
Marc d. Paradis United States
Keyla Perez Australia
Adam P. Gunn Australia
Deborah J. Tew Australia
Andrea Schlicksupp Germany
Steve Macfarlane Australia
Mark Greenough Australia
Christa J. Maynard Australia
Christine Mavros Australia
Darryl Carrington
Citations per year, relative to Darryl Carrington Darryl Carrington (= 1×) peers Christine Mavros

Countries citing papers authored by Darryl Carrington

Since Specialization
Citations

This map shows the geographic impact of Darryl Carrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darryl Carrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darryl Carrington more than expected).

Fields of papers citing papers by Darryl Carrington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darryl Carrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darryl Carrington. The network helps show where Darryl Carrington may publish in the future.

Co-authorship network of co-authors of Darryl Carrington

This figure shows the co-authorship network connecting the top 25 collaborators of Darryl Carrington. A scholar is included among the top collaborators of Darryl Carrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darryl Carrington. Darryl Carrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Cherny, Robert A., Kevin J. Barnham, Ashley I. Bush, et al.. (2006). P4–435: PBT2, a novel MPAC for the treatment of Alzheimer's disease. Alzheimer s & Dementia. 2(3S_Part_21). 2 indexed citations
2.
Tickler, Anna K., Danielle G. Smith, Giuseppe D. Ciccotosto, et al.. (2005). Methylation of the Imidazole Side Chains of the Alzheimer Disease Amyloid-β Peptide Results in Abolition of Superoxide Dismutase-like Structures and Inhibition of Neurotoxicity. Journal of Biological Chemistry. 280(14). 13355–13363. 99 indexed citations
3.
Ciccotosto, Giuseppe D., Deborah J. Tew, Cyril C. Curtain, et al.. (2004). Enhanced Toxicity and Cellular Binding of a Modified Amyloid β Peptide with a Methionine to Valine Substitution. Journal of Biological Chemistry. 279(41). 42528–42534. 92 indexed citations
4.
Barnham, Kevin J., Fredrik Hæffner, Giuseppe D. Ciccotosto, et al.. (2004). Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease β‐amyloid. The FASEB Journal. 18(12). 1427–1429. 230 indexed citations
5.
Ritchie, Craig, Ashley I. Bush, Andrew Mackinnon, et al.. (2003). Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease. Archives of Neurology. 60(12). 1685–1685. 810 indexed citations breakdown →
6.
Barnham, Kevin J., Giuseppe D. Ciccotosto, Anna K. Tickler, et al.. (2003). Neurotoxic, Redox-competent Alzheimer's β-Amyloid Is Released from Lipid Membrane by Methionine Oxidation. Journal of Biological Chemistry. 278(44). 42959–42965. 159 indexed citations
7.
Hurlbert, Robert B., et al.. (1980). Mechanism of tumor inhibition by alanosine. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Mavros Breakdown of academic impact, for papers by Fedá E. Ali Breakdown of academic impact, for papers by Marc d. Paradis Breakdown of academic impact, for papers by Keyla Perez Breakdown of academic impact, for papers by Adam P. Gunn Breakdown of academic impact, for papers by Deborah J. Tew Breakdown of academic impact, for papers by Andrea Schlicksupp Breakdown of academic impact, for papers by Steve Macfarlane Breakdown of academic impact, for papers by Mark Greenough Breakdown of academic impact, for papers by Christa J. Maynard
Rankless by CCL
2026